SCHEMBL13977909

SCHEMBL13977909

Nc1cc(S)c2ncccc2c1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PSMD14 O00487 4/20 0.62
COPS5 Q92905 4/20 0.62
KDM4E B2RXH2 4/20 0.48
TSHR P16473 3/20 0.48
TP53 P04637 2/20 0.48
HSP90AA1 P07900 2/20 0.48
MAPT P10636 2/20 0.48
HTT P42858 2/20 0.48
SMN1; SMN2 Q16637 2/20 0.48
ALDH1A1 P00352 2/20 0.48
HSP90AB1 P08238 1/20 0.48
CASP1 P29466 1/20 0.48
ATM Q13315 1/20 0.48
HSD17B10 Q99714 1/20 0.48
LMNA P02545 2/20 0.47
CCR1 P32246 4/20 0.45
CCR8 P51685 4/20 0.45
CCR5 P51681 2/20 0.45
MMP2 P08253 2/20 0.45
GMNN O75496 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7548538 0.80 KDM4E (0.52) PSMD14COPS5KDM4ETSHRTP53
SCHEMBL2938512 0.77 LMNA (0.56) PSMD14COPS5KDM4ETSHRTP53
SCHEMBL15652298 0.77 KDM4E (0.48) PSMD14COPS5KDM4ETSHRTP53
SCHEMBL6526164 0.77 KDM4E (0.62) KDM4ETSHRTP53HSP90AA1MAPT
SCHEMBL15007502 0.77 KDM4E (0.48) PSMD14COPS5KDM4ETSHRTP53
SCHEMBL2944756 0.77 CCR1 (0.55) KDM4ETSHRTP53HSP90AA1MAPT
SCHEMBL18526845 0.77 PSMD14 (1.00) PSMD14COPS5KDM4ETSHRTP53
SCHEMBL25961779 0.77 PSMD14 (0.62) PSMD14COPS5KDM4ETSHRTP53
SCHEMBL2942804 0.77 KDM4E (0.44) PSMD14COPS5KDM4ETSHRTP53
SCHEMBL15217632 0.73 CCR1 (0.62) PSMD14COPS5KDM4ETSHRTP53

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 US disclosed
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-08-21 US disclosed
WO-2014066506-A2 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION CLEAVE BIOSCIENCES, INC. (US) 2014-05-01 WO disclosed
WO-2012158435-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION ZHOU HAN-JIE (US) 2012-11-22 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20140235548-A1 COMPOSITIONS AND METHODS FOR JAMM PROTEIN INHIBITION USP24, USP36, USP39 PSMD14 7/4885COPS5 39/4885KDM4E 2753/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.